Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myalept in partial lipodystrophy
NCT02654977Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Sep 2015
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin in familial partial lipodystrophy (FPLD), sponsored by University of Michigan. Started Sep 2015; status: completed.
02
Drugs
metreleptin
03
Conditions
familial partial lipodystrophy (FPLD)
Beyond the preview
Go deeper on NCT02654977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654977.